DNA X grants acting CEO Mike Mulica cash award in lieu of annual stock units
SONM•DNA X approved a cash award for acting CEO and Executive Chairman Mike Mulica, initially valued at $50,000, with payment due when it vests at the earlier of the 2027 annual stockholder meeting or a change in control.




